These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8390242)
1. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Imamura F; Horai T; Mukai M; Shinkai K; Sawada M; Akedo H Biochem Biophys Res Commun; 1993 Jun; 193(2):497-503. PubMed ID: 8390242 [TBL] [Abstract][Full Text] [Related]
2. [Mechanism of tumor cell invasion studied by a culture model--modification of invasiveness by host mediators]. Mukai M; Shinkai K; Yoshioka K; Imamura F; Akedo H Hum Cell; 1993 Sep; 6(3):194-8. PubMed ID: 8297816 [TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells. Qi C; Park JH; Gibbs TC; Shirley DW; Bradshaw CD; Ella KM; Meier KE J Cell Physiol; 1998 Feb; 174(2):261-72. PubMed ID: 9428812 [TBL] [Abstract][Full Text] [Related]
4. Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts. Taves J; Rastedt D; Canine J; Mork D; Wallert MA; Provost JJ Arch Biochem Biophys; 2008 Sep; 477(1):60-6. PubMed ID: 18539131 [TBL] [Abstract][Full Text] [Related]
5. Interactions of lung cancer cells with the human mesothelial cell monolayer: an in vitro model for cancer invasion. Horai T; Imamura F; Nakae T; Nakamura S; Mukai M; Shinkai K; Higashino K; Akedo H Jpn J Clin Oncol; 1992 Apr; 22(2):67-72. PubMed ID: 1320140 [TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid-depleted serum, hepatocyte growth factor and stem cell growth factor stimulate colony growth of small cell lung cancer cells through a calcium-independent pathway. Seckl MJ; Seufferlein T; Rozengurt E Cancer Res; 1994 Dec; 54(23):6143-7. PubMed ID: 7525056 [TBL] [Abstract][Full Text] [Related]
7. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling. Stam JC; Michiels F; van der Kammen RA; Moolenaar WH; Collard JG EMBO J; 1998 Jul; 17(14):4066-74. PubMed ID: 9670021 [TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790 [TBL] [Abstract][Full Text] [Related]
9. An experimental model for ovarian tumor invasion of cultured mesothelial cell monolayer. Sawada M; Shii J; Akedo H; Tanizawa O Lab Invest; 1994 Mar; 70(3):333-8. PubMed ID: 8145527 [TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor. Park KS; Lee HY; Lee SY; Kim MK; Kim SD; Kim JM; Yun J; Im DS; Bae YS FEBS Lett; 2007 Sep; 581(23):4411-6. PubMed ID: 17719584 [TBL] [Abstract][Full Text] [Related]
11. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725 [TBL] [Abstract][Full Text] [Related]
12. S1P regulation of ovarian carcinoma invasiveness. Smicun Y; Reierstad S; Wang FQ; Lee C; Fishman DA Gynecol Oncol; 2006 Dec; 103(3):952-9. PubMed ID: 16956652 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Yoshioka K; Nakamori S; Itoh K Cancer Res; 1999 Apr; 59(8):2004-10. PubMed ID: 10213513 [TBL] [Abstract][Full Text] [Related]
14. Neurotransmitter release from lysophosphatidic acid stimulated PC12 cells: involvement of lysophosphatidic acid receptors. Shiono S; Kawamoto K; Yoshida N; Kondo T; Inagami T Biochem Biophys Res Commun; 1993 Jun; 193(2):667-73. PubMed ID: 8390248 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK. Stähle M; Veit C; Bachfischer U; Schierling K; Skripczynski B; Hall A; Gierschik P; Giehl K J Cell Sci; 2003 Sep; 116(Pt 18):3835-46. PubMed ID: 12902401 [TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid increases phosphatidic acid formation, phospholipase D activity and degranulation by human neutrophils. Tou JS; Gill JS Cell Signal; 2005 Jan; 17(1):77-82. PubMed ID: 15451027 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA). Mukai M; Imamura F; Ayaki M; Shinkai K; Iwasaki T; Murakami-Murofushi K; Murofushi H; Kobayashi S; Yamamoto T; Nakamura H; Akedo H Int J Cancer; 1999 Jun; 81(6):918-22. PubMed ID: 10362139 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. Shinkai K; Akedo H; Mukai M; Imamura F; Isoai A; Kobayashi M; Kitagawa I Jpn J Cancer Res; 1996 Apr; 87(4):357-62. PubMed ID: 8641966 [TBL] [Abstract][Full Text] [Related]
19. Involvement of small GTPases Rho and Rac in the invasion of rat ascites hepatoma cells. Imamura F; Mukai M; Ayaki M; Takemura K; Horai T; Shinkai K; Nakamura H; Akedo H Clin Exp Metastasis; 1999 Mar; 17(2):141-8. PubMed ID: 10411106 [TBL] [Abstract][Full Text] [Related]
20. Serum requirement for in vitro invasion by tumor cells. Imamura F; Horai T; Mukai M; Shinkai K; Akedo H Jpn J Cancer Res; 1991 May; 82(5):493-6. PubMed ID: 1905695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]